Raymond James Trust N.A. boosted its position in Innospec Inc. (NASDAQ:IOSP – Free Report) by 7.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,106 shares of the specialty chemicals company’s stock after purchasing an additional 155 shares during the quarter. Raymond James Trust N.A.’s holdings in Innospec were worth $238,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. DekaBank Deutsche Girozentrale bought a new position in shares of Innospec during the 1st quarter worth approximately $66,000. CWM LLC increased its position in shares of Innospec by 239.6% during the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock worth $78,000 after purchasing an additional 448 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Innospec by 503.9% during the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after purchasing an additional 650 shares during the last quarter. nVerses Capital LLC boosted its position in shares of Innospec by 200.0% in the 3rd quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock worth $102,000 after purchasing an additional 600 shares in the last quarter. Finally, Point72 DIFC Ltd purchased a new position in Innospec during the 2nd quarter worth $184,000. 96.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.
Insider Buying and Selling
In related news, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total transaction of $127,222.20. Following the completion of the transaction, the director now owns 9,028 shares of the company’s stock, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.35% of the company’s stock.
Innospec Stock Up 0.0 %
IOSP stock opened at $117.66 on Friday. The stock has a market capitalization of $2.93 billion, a PE ratio of 20.53 and a beta of 1.08. Innospec Inc. has a 52 week low of $103.97 and a 52 week high of $133.71. The firm has a 50 day moving average of $114.30 and a 200 day moving average of $118.48.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.35. The firm had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The business’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.59 earnings per share. On average, equities research analysts expect that Innospec Inc. will post 5.88 earnings per share for the current year.
Innospec Increases Dividend
The company also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th were paid a $0.79 dividend. This represents a dividend yield of 1.3%. This is a boost from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date was Monday, November 18th. Innospec’s dividend payout ratio (DPR) is presently 27.57%.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also
- Five stocks we like better than Innospec
- How to Find Undervalued Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Utilities Stocks Explained – How and Why to Invest in Utilities
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Calculate Stock Profit
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.